Recruiting now—Ages 18 Years and up
Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
Sponsor: Technische Universität Dresden · NCT07148193 on ClinicalTrials.gov ↗
Conditions studied
SarcomaSurvivorshipQuality of Life (QOL)Medical Care
What it tests
- No intervention (observational study)other
Where it's running5 sites
5 international sites
- Recruiting now
Technical University Dresden
Dresden, Saxony, Germany
- Tanja Strukelj, M.A.(contact)+493514587056[email protected]
- Opening soon
University Hospital Essen
Essen, Germany
- Uta Dirksen, Prof. Dr.(contact)
- Recruiting now
NCT Heidelberg
Heidelberg, Germany
- Richard F. Schlenk, Prof. Dr.(contact)
- Recruiting now
Sarcoma Center Mannheim
Mannheim, Germany
- Jens Jakob, Prof. Dr.(contact)
- Recruiting now
Deutsche Sarkom-Stiftung
Wölfersheim, Germany
- Markus Wartenberg(contact)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Diagnosis of sarcoma according to the International Classification of Diseases for Oncology (ICD-O) and World Health Organization (WHO) classification, including soft tissue sarcoma, bone sarcoma, and GIST * At least 5 years since initial sarcoma diagnosis * With or without active disease * Age ≥18 years at the time of study participation Exclusion Criteria: * Diagnosis of Desmoid tumors * Inability to complete a structured questionnaire (e.g., due to insufficient German language skills, cognitive impairment, dementia)
Updated 2025-12-08 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.